You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  BOOKS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Advances in Biochemical Psychopharmacology: GABA and Benzodiazepine Receptor Subtypes: Molecular Biology, Pharmacology, and Clinical Aspects

edited by G. Biggio and E. Costa, 255 pp, $85, New York, NY, Raven Press, 1990.

Jean M. Bidlack, PhD, Reviewer
Rochester, NY

Arch Neurol. 1991;48(11):1114-1115.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This volume presents the proceedings of the Sixth Capo Boi Conference on Neuroscience, held in Villasimius, Italy, in June 1989. The structural heterogeneity of the {gamma}-aminobutyric acid (GABA)A receptor and its possible impact on discrete functional differences between receptor variants is discussed in great detail. The allosteric modulation of the receptor-anion channel function by the benzodiazepine receptor is discussed at the molecular level. During the past 5 years, the progress of our understanding of the GABAergic synaptic function has contributed a structural complexity. Since the GABAA receptor constitutes subunits, determining its molecular characteristics and how the different subunits interact has been a difficult problem that has just recently been solved. Assessing whether or not all possible combinations of the GABAA receptor subtypes are expressed and functional is the focus of this volume. The benzodiazepine binding sites are no longer exclusively linked to GABAergic function. With the cloning . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.